A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | I approve | Name | Institution(s) | Department | Address | ORCID | Present Address (if different from current) | Conflict of interest disclosure | Funding acknowledgements | ||||||||||||||||||
2 | X | Matthew C. Robinson | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | matthew.robinson@postera.ai | |||||||||||||||||||||
3 | x | Nir London | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | nir.london@weizmann.ac.il | 0000-0003-2687-0699 | N.L. currently serves on the scientific advisory board of Monte Rosa Therapeutics, Larkspur Biosciences and Tesseract Medicines | N.L. would like to acknowledge funding from the Israel Science Foundation (grant no. 3824/19), the Estate of Emile Mimran, Honey and Dr. Barry Sherman Lab, Dr. Barry Sherman Institute for Medicinal Chemistry and Nelson P. Sirotsky. | ||||||||||||||||||
4 | x | Efrat Resnick | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | efrat.resnick@weizmann.ac.il | 0000-0001-9497-0216 | ||||||||||||||||||||
5 | x | Daniel Zaidmann | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | daniel.zaidman@gmail.com | |||||||||||||||||||||
6 | x | Paul Gehrtz | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | paul.gehrtz@merckgroup.com | Merck Healthcare KGaA, Frankfurter Str 250, 64293 Darmstadt, Germany | ||||||||||||||||||||
7 | X | Rambabu N. Reddi | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | rambabu.reddi78@gmail.com | |||||||||||||||||||||
8 | x | Ronen Gabizon | The Weizmann Institute of Science | Chemical and Structural Biology | Hertzl 234 st. Rehovot, Israel, 7610001 | ronen.gabizon@weizmann.ac.il | |||||||||||||||||||||
9 | X | Haim Barr | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | haim.barr@weizmann.ac.il | 0000-0001-9192-3983 | ||||||||||||||||||||
10 | X | Shirly Duberstein | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | shirly.valter@weizmann.ac.il | |||||||||||||||||||||
11 | X | Hadeer Zidane | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | hadeer.zidane@weizmann.ac.il | |||||||||||||||||||||
12 | X | Khriesto Shurrush | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | khriesto.shurrush@weizmann.ac.il | |||||||||||||||||||||
13 | X | Galit Cohen | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | galit.cohen@weizmann.ac.il | |||||||||||||||||||||
14 | x | Leonardo J. Solmesky | The Weizmann Institute of Science | Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine | Hertzl 234 st. Rehovot, Israel, 7610001 | leonardo.solmesky@weizmann.ac.il | |||||||||||||||||||||
15 | x | Alpha Lee | PostEra Inc.; University of Cambridge | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | alpha.lee@postera.ai | ||||||||||||||||||||||
16 | x | Andrew Jajack | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | ajajack@gmail.com | |||||||||||||||||||||
17 | x | Milan Cvitkovic | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | mwcvitkovic@gmail.com | 0000-0003-4188-452X | ||||||||||||||||||||
18 | x | Jin Pan | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | jin@thepanda.family | |||||||||||||||||||||
19 | x | Ruby Pai | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | rubyjpai@gmail.com | |||||||||||||||||||||
20 | X | Emily Grace Ripka | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | emily.ripka@postera.ai | |||||||||||||||||||||
21 | x | Luong Nguyen | PostEra Inc. | Technology | 1 Broadway, 14th Floor, Cambridge, MA, 02142 | luong.nguyen@postera.ai | |||||||||||||||||||||
22 | x | Mikhail Shafeev | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | m.shafeev@mail.enamine.net | |||||||||||||||||||||
23 | x | Tatiana Matviiuk | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | t.matviyuk@enamine.net | |||||||||||||||||||||
24 | X | Oleg Michurin | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | o.michurin@enamine.net | |||||||||||||||||||||
25 | x | Eugene Chernyshenko | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | y.chernyshenko@enamine.net | |||||||||||||||||||||
26 | X | Vitaliy A. Bilenko | Enamine Ltd, Taras Shevchenko National University of Kyiv | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | v.bilenko@enamine.net | |||||||||||||||||||||
27 | X | Serhii O. Kinakh | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | s.kinakh@enamine.net | |||||||||||||||||||||
28 | x | Ivan G. Logvinenko | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | i.logvinenko@enamine.net | |||||||||||||||||||||
29 | X | Kostiantyn P. Melnykov | Enamine Ltd, Taras Shevchenko National University of Kyiv | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine, 60 Volodymyrska Street, Kyiv, Ukraine, 01033 | k.melnykov@enamine.net | |||||||||||||||||||||
30 | x | Victor D. Huliak | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | v.huliak@mail.enamine.net | |||||||||||||||||||||
31 | x | Igor S. Tsurupa | Enamine Ltd | Synthetic Chemistry | 78 Chervonotkatska Street, 02094 Kyiv, Ukraine | igortsurupa@gmail.com | |||||||||||||||||||||
32 | x | Marian Gorichko | Taras Shevchenko National University of Kyiv | Organic Chemistry | 60 Volodymyrska Street, Kyiv, Ukraine, 01033 | 417lab@gmail.com | 0000-0002-5401-9597 | ||||||||||||||||||||
33 | Aarif Shaikh | Sai Life Sciences | Synthetic Chemistry | Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201 | aarif.s@sailife.com | ||||||||||||||||||||||
34 | x | Jakir Pinjari | Sai Life Sciences | Synthetic Chemistry | Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201 | jakir.pinjari@sparcmail.com | Sun Pharma Advanced Research Company (SPARC), Baroda, India. | ||||||||||||||||||||
35 | x | Vishwanath Swamy | Sai Life Sciences | Synthetic Chemistry | Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201 | vishwanath.swamy@tcgls.com | TCG Life Sciences, Pune, India. | ||||||||||||||||||||
36 | X | Maneesh Pingle | Sai Life Sciences | Synthetic Chemistry | Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201 | maneesh.p@sailife.com | |||||||||||||||||||||
37 | X | Sarma BVNBS | Sai Life Sciences | Synthetic Chemistry | Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201 | sarma.b@sailife.com | |||||||||||||||||||||
38 | X | Anthony Aimon | Diamond Light Source Ltd; Research Complex at Harwell | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | anthony.aimon@gmail.com | 0000-0002-9135-129X | |||||||||||||||||||||
39 | X | Frank von Delft | Diamond Light Source Ltd; University of Oxford; Research Complex at Harwell; University of Johannesburg | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Centre for Medicine Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom;Department of Biochemistry, University of Johannesburg, Auckland Park, 2006, South Africa | frank.von-delft@diamond.ac.uk | 0000-0003-0378-0017 | F.v.D. acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z) and BBSRC (grant no. BB/T003677/1) | ||||||||||||||||||||
40 | X | Daren Fearon | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | daren.fearon@diamond.ac.uk | 0000-0003-3529-7863 | ||||||||||||||||||||
41 | X | Charles W.E. Tomlinson | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | charlie.tomlinson@diamond.ac.uk | 0000-0002-1845-6028 | ||||||||||||||||||||
42 | x | Blake H. Balcomb | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | blake.h.balcomb@diamond.ac.uk | 0000-0001-7599-8467 | ||||||||||||||||||||
43 | x | Ryan M. Lithgo | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | ryan.lithgo@diamond.ac.uk | 0000-0002-4706-9916 | ||||||||||||||||||||
44 | x | Jasmin C. Aschenbrenner | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | jasmin.aschenbrenner@diamond.ac.uk | 0000-0002-4318-0481 | ||||||||||||||||||||
45 | x | Louise E. Dunnett | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | louise.dunnett@diamond.ac.uk | 0000-0001-6710-6959 | ||||||||||||||||||||
46 | Alice Douangamath | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | alice.douangamath@gmx.de | 0000-0002-9196-8644 | |||||||||||||||||||||
47 | x | Alex Dias | Diamond Light Source Ltd; Research Complex at Harwell | CEO | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | alexandre.dias@diamond.ac.uk | 0000-0003-3609-7003 | ||||||||||||||||||||
48 | x | Ailsa Powell | Diamond Light Source Ltd; Research Complex at Harwell | CEO | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | ailsa.powell@diamond.ac.uk | 0000-0002-0462-2240 | ||||||||||||||||||||
49 | x | Jose Brandao Neto | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | jose.brandao-neto@diamond.ac.uk | 0000-0001-6015-320X | ||||||||||||||||||||
50 | x | Rachael Skyner | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | Rachael.Skyner@omass.com | 0000-0003-3614-6661 | ||||||||||||||||||||
51 | X | Warren Thompson | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | warren.thompson@diamond.ac.uk | 0000-0003-1474-7810 | ||||||||||||||||||||
52 | X | Tyler Gorrie-Stone | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | tyler.gorrie-stone@genomicsplc.com | 0000-0002-1817-1495 | ||||||||||||||||||||
53 | X | Martin A. Walsh | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | martin.walsh@diamond.ac.uk | 0000-0001-5683-1151 | ||||||||||||||||||||
54 | X | C. David Owen | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | david.owen@diamond.ac.uk | 0000-0001-5774-8202 | ||||||||||||||||||||
55 | X | Petra Lukacik | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | petra.lukacik@diamond.ac.uk | 0000-0002-3179-7273 | ||||||||||||||||||||
56 | X | Claire Strain-Damerell | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | claire.strain-damerell@diamond.ac.uk | 0000-0003-4964-2090 | ||||||||||||||||||||
57 | x | Halina Mikolajek | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | halina.mikolajek@diamond.ac.uk | 0000-0003-0776-9974 | ||||||||||||||||||||
58 | X | Sam Horrell | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | sam.horrell@diamond.ac.uk | 0000-0001-6355-8640 | ||||||||||||||||||||
59 | X | Peter G. Marples | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | peter.marples@diamond.ac.uk | 0000-0002-8787-7969 | ||||||||||||||||||||
60 | x | Lizbé Koekemoer | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | lizbe.koekemoer@cmd.ox.ac.uk | 0000-0001-9226-9127 | L.K. acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z) | |||||||||||||||||||
61 | x | Tobias Krojer | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | tobias.krojer@maxiv.lu.se | 0000-0003-0661-0814 | MAX IV Laboratory, Fotongatan 2, 224 84 Lund, Sweden | T.K. acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z) | ||||||||||||||||||
62 | x | Michael Fairhead | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | michael.fairhead@cmd.ox.ac.uk | 0000-0001-5361-3933 | M.F. acknowledges funding from the BBSRC (grant no. BB/T003677/1) | |||||||||||||||||||
63 | X | Elizabeth M. MacLean | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | beth.maclean@cmd.ox.ac.uk | 0000-0003-1680-4292 | E.M. acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z) | |||||||||||||||||||
64 | X | Andrew Thompson | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | thompson.a@wehi.edu.au | 0000-0002-3910-2317 | Walter and Eliza Hall Institute. 1G Royal Parade, Parkville 3052, Victoria, Australia | |||||||||||||||||||
65 | X | Conor Francis Wild | Diamond Light Source Ltd; Research Complex at Harwell | Life Sciences | Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom | c.wild@diamond.ac.uk | 0000-0003-0654-8141 | ||||||||||||||||||||
66 | X | Mihaela D. Smilova | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | mihaela.smilova@gmail.com | 0000-0001-6255-7312 | ||||||||||||||||||||
67 | X | Nathan Wright | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | nathan.wright@cmd.ox.ac.uk | 0000-0001-5035-8180 | N.W. acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z) | |||||||||||||||||||
68 | X | Annette von Delft | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | annette.vondelft@cmd.ox.ac.uk | 0000-0002-7699-8140 | A.v.D acknowledges funding from the Wellcome Trust (grant no. 106169/ZZ14/Z), and the Oxford Biomedical Research Centre, BRC, NIHR | |||||||||||||||||||
69 | x | Carina Gileadi | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | carinagileadi@hotmail.com | Salary support received from the John Fell Fund Oxford | ||||||||||||||||||||
70 | x | Victor L. Rangel | School of Pharmaceutical Sciences of Ribeirao Preto | Pharmaceutical Sciences | Avenida do Café, s/nºRibeirão Preto - SP/CEP 14040-903 | victorlopesrangel92@gmail.com | 0000-0002-7580-3452 | Evotec (UK) Ltd. 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RZ, United Kingdom | Financed by National Council for Scientific and Technological Development
(CNPq, grant number 141945/2018-4) and financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) – Finance Code 001 | ||||||||||||||||||
71 | X | Christopher J. Schofield | University of Oxford | Department of Chemistry | Chemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdom | christopher.schofield@chem.ox.ac.uk | 0000-0002-0290-6565 | Supported by the Univeristy of Oxford COVID-19 Research Resposne Fund, the Wellcome Trust, CRUK and The BBSRC | |||||||||||||||||||
72 | x | Eidarus Salah | University of Oxford | Department of Chemistry | Chemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdom | eidarus.salah@chem.ox.ac.uk | 0000-0001-7552-4966 | Supported by the Univeristy of Oxford COVID-19 Research Resposne Fund, the Wellcome Trust, CRUK and The BBSRC | |||||||||||||||||||
73 | X | Tika R. Malla | University of Oxford | Nuffield Department of Medicine | Centre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | tika.malla@cmd.ox.ac.uk | 0000-0003-4989-6410 | Supported by the Univeristy of Oxford COVID-19 Research Resposne Fund, the Wellcome Trust, CRUK and The BBSRC | |||||||||||||||||||
74 | X | Anthony Tumber | University of Oxford | Department of Chemistry | Chemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdom | anthony.tumber@chem.ox.ac.uk | Supported by the Univeristy of Oxford COVID-19 Research Resposne Fund, the Wellcome Trust, CRUK and The BBSRC | ||||||||||||||||||||
75 | X | Tobias John | University of Oxford | Department of Chemistry | Chemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdom | tobias.john1@gmx.de | 0000-0002-6123-595X | AMSilk, Anna-Sigmund-Str. 1-3, 82061 Neuried | T.J. was supported by the Oxford-GSK-Crick Doctoral Programme in Chemical Biology, EPSRC (EP/R512060/1) and GlaxoSmithKline | ||||||||||||||||||
76 | X | Ioannis Vakonakis | University of Oxford | Department of Biochemistry | South Parks Road, Oxford OX1 3QU | jvakon@gmail.com | 0000-0002-4726-0446 | Lonza Biologics, Lonza Ltd, Lonzastrasse, CH-3930 Visp, Switzerland. | Supported by the University of Oxford COVID-19 Research Response Fund | ||||||||||||||||||
77 | X | Anastassia L. Kantsadi | University of Oxford | Department of Biochemistry | South Parks Road, Oxford OX1 3QU | Akantsadi@uth.gr | Department of Biochemistry and Biotechnology, University of Thessaly, Greece | Supported by the Oxford Glycobiology Institute Endowment | |||||||||||||||||||
78 | X | Nicole Zitzmann | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute and Kavli Institute of Nanoscience Discovery; South Parks Road, Oxford OX1 3QU | nicole.zitzmann@bioch.ox.ac.uk | 0000-0003-1969-4949 | Supported by the University of Oxford COVID-19 internal funds, the Oxford Glycobiology Institute Endowment, and grants to Biochemistry Department Oxford, the Dunn School of Pathology. | |||||||||||||||||||
79 | X | Juliane Brun | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute and Kavli Institute of Nanoscience Discovery; South Parks Road, Oxford OX1 3QU | juliane.brun@bioch.ox.ac.uk | 0000-0002-0964-3681 | Supported by the University of Oxford COVID-19 internal funds, the Oxford Glycobiology Institute Endowment, and grants to Biochemistry Department Oxford, the Dunn School of Pathology. | |||||||||||||||||||
80 | x | J. L. Kiappes | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute; South Parks Road, Oxford OX1 3QU | j.l.kiappes@ucl.ac.uk | 0000-0001-6697-6776 | Department of Chemistry, 20 Gordon Street, London WC1H 0AJ | Supported by the University of Oxford COVID-19 internal funds, the Oxford Glycobiology Institute Endowment, and grants to Biochemistry Department Oxford, the Dunn School of Pathology. | ||||||||||||||||||
81 | x | Michelle Hill | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute; South Parks Road, Oxford OX1 3QU | michelle.hill@path.ox.ac.uk | 0000-0002-9289-5811 | Sir William Dunn School of Pathology, South Parks Road, Oxford. OX1 3RE | Supported by the University of Oxford COVID-19 internal funds, the Oxford Glycobiology Institute Endowment, and grants to Biochemistry Department Oxford, the Dunn School of Pathology. | ||||||||||||||||||
82 | x | Karolina D Witt | University of Oxford | Nuffield Department of Medicine | Pandemic Sciences Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UK | karolina.witt@ndm.ox.ac.uk | 0000-0001-6230-2133 | ||||||||||||||||||||
83 | x | Dominic S Alonzi | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute; South Parks Road, Oxford OX1 3QU | dominic.alonzi@bioch.ox.ac.uk | 0000-0002-1330-9109 | ||||||||||||||||||||
84 | X | Laetitia L Makower | University of Oxford | Department of Biochemistry | Oxford Glycobiology Institute; South Parks Road, Oxford OX1 3QU | lettymakower@gmail.com | 0000-0003-2385-3973 | ||||||||||||||||||||
85 | X | Finny S. Varghese | Radboud University Medical Center | Department of Medical Microbiology | Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands | F.Varghese@uniqure.com | 0000-0002-7900-5482 | uniQure Biopharma, Amsterdam, the Netherlands | none | ||||||||||||||||||
86 | X | Gijs J. Overheul | Radboud University Medical Center | Department of Medical Microbiology | Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands | Gijs.Overheul@radboudumc.nl | 0000-0002-8356-8165 | none | |||||||||||||||||||
87 | X | Pascal Miesen | Radboud University Medical Center | Department of Medical Microbiology | Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands | pascal.miesen@radboudumc.nl | 0000-0002-6378-0871 | none | PM acknowledges support from the Dutch Research Council (grant no. VI.Veni.202.035) | ||||||||||||||||||
88 | X | Ronald P. van Rij | Radboud University Medical Center | Department of Medical Microbiology | Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands | ronald.vanrij@radboudumc.nl | 0000-0003-0221-4689 | none | RPvR acknowledges funding from the Dutch Research Council (grant no. 016.VICI.170.090) | ||||||||||||||||||
89 | X | Jitske Jansen | RWTH Aachen University | Institute of Experimental Medicine and Systems Biology | Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Pauwelsstrasse 30 52074 Aachen, Germany. | Jijansen@radboudumc.nl | 0000-0003-0513-6102 | none | JJ acknowledges funding from the Dutch Research Council (grant no. Veni 091.501.6181.01.36) | ||||||||||||||||||
90 | X | Bart Smeets | Radboud University Medical Center | Department of Pathology | Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands | Bart.Smeets@radboudumc.nl | 0000-0002-8466-3367 | BS acknowledges funding from the Dutch Research Council (grant no. VIDI 016.156.363) | |||||||||||||||||||
91 | x | Susana Tomásio | Collaborative Drug Discovery | Nine Hills Rd, Cambridge, CB2 1GE, UK | Stomasio@collaborativedrug.com | ||||||||||||||||||||||
92 | x | Charlie Weatherall | Collaborative Drug Discovery | 1633 Bayshore Hwy, Burlingame, CA 94010, USA | cweatherall@collaborativedrug.com | ||||||||||||||||||||||
93 | x | Mariana Vaschetto | Collaborative Drug Discovery | Nine Hills Rd, Cambridge, CB2 1GE, UK | mariana@collaborativedrug.com | ||||||||||||||||||||||
94 | X | Hannah Bruce Macdonald | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program | 1275 York Ave, New York, NY 10065 | hannah.brucemacdonald@choderalab.org | 0000-0002-5562-6866 | Charm Therapeutics, 7 Pancras Sq, London, N1C 4AG, UK | |||||||||||||||||||
95 | X | John D. Chodera | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program | 1275 York Ave ZRC 6-South, New York, NY 10065 | john.chodera@choderalab.org | 0000-0003-0542-119X | JDC is a current member of the Scientific Advisory Board of OpenEye Scientific Software, Redesign Science, Ventus Therapeutics, and Interline Therapeutics, and has equity interests in Rede and Interline Therapeutics. The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, Bayer, XtalPi, Interline Therapeutics, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V.\ Gerstner Young Investigator Award, and the Sloan Kettering Institute. A complete funding history for the Chodera lab can be found at http://choderalab.org/funding.The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, Bayer, XtalPi, Foresite Laboratories, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, and the Sloan Kettering Institute. A complete funding history for the Chodera lab can be found at http://choderalab.org/funding | JDC acknowledges support from NSF RAPID 2033426, NIH grant P30 CA008748, NIH grant R01 GM121505, NIH grant R01 GM132386, NSF CHE-1904822, and the Sloan Kettering Institute. | ||||||||||||||||||
96 | x | Dominic A. Rufa | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program ; Tri-Institutional Program in Chemical Biology | 1275 York Ave ZRC 6-South, New York, NY 10065 | dominic.rufa@choderalab.org | 0000-0003-0930-9445 | DAR acknowledges support from the Tri-Institutional Program in Chemical Biology | |||||||||||||||||||
97 | X | Matthew Wittmann | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program | 1275 York Ave ZRC 6-South, New York, NY 10065 | mcwitt@gmail.com | 0000-0003-0948-4083 | 0000-0003-0948-4083 | MW acknowledges support from NSF RAPID 2033426 and the Sloan Kettering Institute | ||||||||||||||||||
98 | X | Melissa L. Boby | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program ; Pharmacology Graduate Program | 1275 York Ave ZRC 6-South, New York, NY 10065 | melissa.boby@choderalab.org | 0000-0003-1920-206X | MB acknowledges support from the Sloan Kettering Institute | |||||||||||||||||||
99 | X | Michael Henry | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program | 1275 York Ave ZRC 6-South, New York, NY 10065 | mike.henry@choderalab.org | 0000-0002-3870-9993 | MB acknowledges support from the Sloan Kettering Institute | |||||||||||||||||||
100 | X | William G. Glass | Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center | Computational and Systems Biology Program | 1275 York Ave ZRC 6-South, New York, NY 10065 | william.glass@choderalab.org | 0000-0002-4099-9280 | Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK |